|
|
Tianlang Nanjing Pharmaceutical Co., LTD. is an emerging pharmaceutical enterprise for professional R&D, production and sales of drugs for external use such as eye drops.
The co***ny was established in 2005 March. Production base is located in Lishui Industrial Park, Nanjing with convenient transportation and beautiful environment. The first-stage of the project covers an area of 70 acres with an investment of 22,000,000 RMB.
Tianlang Pharmaceuticals has a perfect internal organization with the staff of nearly 90 people, 80% of them have the pharmaceutical, chemical and other professional background and 30% of them have intermediate professional title or above. More than 90% of employees are experienced in production, sales and management for .many years.
The production workshops of the first-stage of the project were constructed according to GMP requirements with a modern production line of eye drops, ear drops, nasal drops, ointment, spray, gel and other dosage forms and strict on-site management as well as the large-scale commercial production capacity. Its annual production is up to 40,000,000. Domestic first-class production equipments, advanced quality testing equipments and environmental control system ensure the quality of co***ny's products.
The co***ny has a young and vibrant sales force and sales network is all over the major provinces of China.
Tianlang Pharmaceuticals has its own R & D center which has a vibrant young team to provide a strong guarantee for the sustainable development of enterprises. With the development of enterprises, Tianlong Pharmaceuticals will manufacture the latestr and better products.
Tianlong Pharmaceuticals has consistently advocated the business philosophy of Integrity, Innovation, Dedication, and Cooperation . Tianlong is willing to cooperate with customers to achieve a brighter future..
|
| Company: |
Nanjing Tianlang Pharmaceuticals Co.,LTD
|
| Contact: |
Ms. MoonA Lee |
| Address: |
No.385 Shengzhou Road |
| Postcode: |
|
| Tel: |
025-58717844 |
| Fax: |
025-52330995 |
| E-mail: |
|
|
|
|
Home
